The Rationality of Antihypertensive and Oral Antidiabetic Patients with Chronic Kidney Disease with Hypertension and or Type 2 Diabetes Mellitus in RSI Siti Khadijah Palembang (ARTIKEL)

Herlina, Herlina (2023) The Rationality of Antihypertensive and Oral Antidiabetic Patients with Chronic Kidney Disease with Hypertension and or Type 2 Diabetes Mellitus in RSI Siti Khadijah Palembang (ARTIKEL). Journal of Physics: Conference Series. pp. 1-6. ISSN 1742-6596

[thumbnail of Puspa_Novita_2019_J._Phys.__Conf._Ser._1282_012086.pdf] Text
Puspa_Novita_2019_J._Phys.__Conf._Ser._1282_012086.pdf

Download (1MB)

Abstract

Chronic Kidney Disease (CKD) is defined as a condition of kidney damage occurring for 3 months or more with a decrease in Glomerular Filtration Rate (GFR) of less than 60 mL/min/1,73m2. The etiology of CKD includes hypertension and type 2 diabetes melitus (DM). The existance of irrational using of antihypertensive drugs and oral antidiabetics in CKD patients with hypertensive etiology and or type 2 diabetes melitus leads to research on the rationality of antihypertensive and oral antidiabetics. This study aims to evaluate the rationality of antihypertensive and or oral antidiabetics of patients with kidney disease with hypertension and or type 2 diabetes mellitus in RSI Siti Khadijah Palembang. This research was done by descriptive analysis method, data collection was done prospectively. The data obtained were 5 samples that suits exclusion criteria as well as 20 samples that suits inclusion criteria. The results of evaluation of antihypertensive drug use were found to be 100% precise indication, 100% precise dose, 95% precise patient, 90% precise drug, and 10% of patients experienced side effects. The evaluation of the use of OAD were 100% precise indication, 100% precise dose, 100% precise patient, 100% precise drug, and 100% of patients had no side effects.

Item Type: Article
Subjects: R Medicine > RS Pharmacy and materia medica > RS200-201 Pharmaceutical dosage forms
R Medicine > RS Pharmacy and materia medica > RS250-252 Commercial preparations. Patent medicines
Divisions: 08-Faculty of Mathematics and Natural Science > 48201-Pharmacy (S1)
Depositing User: Herlina Herlina
Date Deposited: 09 Jun 2023 12:50
Last Modified: 09 Jun 2023 12:50
URI: http://repository.unsri.ac.id/id/eprint/107736

Actions (login required)

View Item View Item